<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />



<meta name="date" content="2026-02-13" />

<title>AMRUTANJAN</title>

<script src="rmdlib/header-attrs-2.30/header-attrs.js"></script>
<script src="rmdlib/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="rmdlib/bootstrap-3.3.5/css/flatly.min.css" rel="stylesheet" />
<script src="rmdlib/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="rmdlib/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="rmdlib/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="rmdlib/navigation-1.1/tabsets.js"></script>
<script src="rmdlib/accessible-code-block-0.0.1/empty-anchor.js"></script>
<link href="rmdlib/font-awesome-6.4.0/css/all.min.css" rel="stylesheet" />
<link href="rmdlib/font-awesome-6.4.0/css/v4-shims.min.css" rel="stylesheet" />
<meta name="description" content="Indian equities analysis, margin reports, risk, etc..." />
<meta property="og:image" content="https://avatars3.githubusercontent.com/u/21966469?s=400&v=4" />

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>










<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->




</head>

<body>


<div class="container-fluid main-container">




<div class="navbar navbar-inverse  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">StockViz</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-globe"></span>
     
    Macro
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-bnd.html">Fixed Income</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-cur.html">Currencies</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-cmdy.html">Commodities</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-arrows-v"></span>
     
    52w H&amp;L
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/52wk-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/52wk-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-rocket"></span>
     
    ATH
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/ath-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/ath-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-magnet"></span>
     
    Drawdowns
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/drawdowns-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/drawdowns-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-train"></span>
     
    Streaks
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/streaks-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/streaks-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-hand-pointer-o"></span>
     
    Indian Indices
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-risk.html">Performance Metrics</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-IN.html">Index Changes</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-MKT-CAP.html">Classification Changes</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-industry.html">Industry Metrics</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-syn.html">Synthetic Indices</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-vol-NIFTY.html">NIFTY Volatility</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-valuations.html">Valuations</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/results-IN.html">Result Dates</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/eq-in/rp-margin.html">Margin Report</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-shopping-bag"></span>
     
    Funds
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports03/mf/rp-IN.html">Indian Mutual Funds</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports03/pms/rp-IN.html">Indian PMS</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-risk.html">US ETFs</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-sector.html">US Sector ETFs</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-country.html">Country $ ETFs</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-percent"></span>
     
    Fama-French
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-industry.html">Industry</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-factors.html">Factors</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-regression.html">Regressions</a>
    </li>
  </ul>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://stockviz.biz">
    <span class="fa fa-home"></span>
     
  </a>
</li>
<li>
  <a href="https://stockviz.substack.com">
    <span class="fa fa-envelope-o"></span>
     
  </a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">



<h1 class="title toc-ignore">AMRUTANJAN</h1>
<h3 class="subtitle">Equity Metrics</h3>
<h4 class="date">February 13, 2026</h4>

</div>


<div id="amrutanjan-health-care-limited" class="section level1">
<h1>Amrutanjan Health Care Limited</h1>
<p><a href="/reports01/index/industry/rp-Pharmaceuticals.html">Pharmaceuticals</a></p>
<div id="annual-returns" class="section level2">
<h2>Annual Returns</h2>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.AMRUTANJAN.fan.png" /></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.AMRUTANJAN.annret.png" /></p>
</div>
<div id="cumulative-returns-and-drawdowns" class="section level2">
<h2>Cumulative Returns and Drawdowns</h2>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.AMRUTANJAN.cumret.png" /></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.AMRUTANJAN.sma.cumret.png" /></p>
<p><br><br></p>
</div>
<div id="fundamentals" class="section level2">
<h2>Fundamentals</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.AMRUTANJAN.eps.png" /></p>
<p><br><br></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.AMRUTANJAN.RevenueFromOperations.png" /></p>
<p><br><br></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.AMRUTANJAN.ebit.png" /></p>
<p><br><br></p>
</div>
<div id="ownership" class="section level2">
<h2>Ownership</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.AMRUTANJAN.ownership.png" /></p>
<p><br><br></p>
</div>
<div id="margined" class="section level2">
<h2>Margined</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.AMRUTANJAN.mtf.png" /></p>
<p><br><br></p>
<p><br />
</p>
</div>
<div id="ai-summary" class="section level2">
<h2>AI Summary</h2>
<p><em>asof: 2025-12-08 </em></p>
<p>Based on the comprehensive review of publicly disclosed regulatory filings and financial statements of <strong>Amrutanjan Health Care Limited (NSE: AMRUTANJAN)</strong> issued between <strong>September and November 2025</strong>, the following analysis outlines the <strong>headwinds, tailwinds, growth prospects, and key risks</strong> for the company. This assessment considers the FY25 audited results, H1 FY26 unaudited performance, voting outcomes, related-party audit processes, tax notices, and strategic developments.</p>
<hr />
<div id="executive-summary" class="section level6">
<h6>üìä <strong>Executive Summary</strong></h6>
<p>Amrutanjan Health Care Limited has demonstrated <strong>stable financial performance and investor governance</strong> in 2025‚Äì26, marked by strong shareholder approval at its AGM, improved profitability sequentially, and a consistent dividend policy. While challenges like segmental losses and a recent adverse tax ruling present <strong>modest headwinds</strong>, the company is seeing <strong>turnarounds in core segments</strong>, prudent capital management, and regulatory compliance. The near-term outlook appears <strong>cautiously optimistic</strong>, with growth driven by OTC products and strategic cost control.</p>
<hr />
</div>
<div id="tailwinds-positive-factors" class="section level6">
<h6>‚úÖ TAILWINDS (Positive Factors)</h6>
<div id="strong-revenue-growth-in-core-otc-segment" class="section level9">
<p class="heading">1. <strong>Strong Revenue Growth in Core OTC Segment</strong></p>
<ul>
<li>The <strong>OTC Products segment</strong>, which contributes ~75% of total revenue, grew <strong>37.7% YoY</strong> in Q2 FY26 (Rs. 8,001 lakhs vs.¬†Rs. 5,697 lakhs in Q1) and improved both <strong>quarterly (3.5%) and H1 (14.8%)</strong> over the prior year.</li>
<li>This indicates <strong>effective marketing and revival</strong> in its flagship health and wellness product line (e.g., Amrutanjan balm, pain relief).</li>
</ul>
</div>
<div id="healthy-profitability-and-marginal-expansion" class="section level9">
<p class="heading">2. <strong>Healthy Profitability and Marginal Expansion</strong></p>
<ul>
<li><strong>PAT (Profit After Tax)</strong> for H1 FY26 rose <strong>35.4% YoY</strong> (Rs. 2,227 lakhs vs.¬†Rs. 1,641 lakhs).</li>
<li><strong>Earnings per Share (EPS)</strong> increased to <strong>‚Çπ7.70 (H1)</strong> from ‚Çπ5.68, driven by strong OTC performance.</li>
<li><strong>Operating margins improved</strong> on higher sales and better inventory management.</li>
</ul>
</div>
<div id="robust-capital-structure-and-liquidity" class="section level9">
<p class="heading">3. <strong>Robust Capital Structure and Liquidity</strong></p>
<ul>
<li><strong>Cash &amp; cash equivalents</strong>: ‚Çπ515.22 crores (vs.¬†‚Çπ730+ crores in prior periods).</li>
<li><strong>Net cash position remains strong</strong> despite H1 negative cash flow from operations (due to working capital outflows, primarily receivables).</li>
<li><strong>Debt remains low</strong>, with total lease liabilities under ‚Çπ200 lakhs ‚Äî an <strong>asset-light and conservative structure</strong>.</li>
</ul>
</div>
<div id="effective-corporate-governance-shareholder-confidence" class="section level9">
<p class="heading">4. <strong>Effective Corporate Governance &amp; Shareholder Confidence</strong></p>
<ul>
<li>All 6 resolutions at the <strong>88th AGM</strong> were approved by <strong>over 99.99% of votes</strong> with <strong>minimal opposition</strong>, reflecting high confidence from shareholders.</li>
<li><strong>Scrutinizer Report confirms transparency</strong> in e-voting and no duplicate or invalid votes, reinforcing governance standards.</li>
</ul>
</div>
<div id="sustained-dividend-payout" class="section level9">
<p class="heading">5. <strong>Sustained Dividend Payout</strong></p>
<ul>
<li><strong>Final Dividend of ‚Çπ2.60/share</strong> (FY24‚Äì25) approved.</li>
<li><strong>First Interim Dividend of ‚Çπ1.00/share</strong> declared for FY25‚Äì26 ‚Äî signaling <strong>consistent shareholder returns</strong>.</li>
<li>Dividend paid: Rs. 751.68 lakhs in H1, covering ~32% of PAT ‚Äî a <strong>sustainable payout ratio</strong>.</li>
</ul>
<hr />
</div>
</div>
<div id="headwinds-challenges" class="section level6">
<h6>‚ö†Ô∏è HEADWINDS (Challenges)</h6>
<div id="profit-decline-in-key-segments-womens-hygiene-beverages" class="section level9">
<p class="heading">1. <strong>Profit Decline in Key Segments: Women‚Äôs Hygiene &amp; Beverages</strong></p>
<ul>
<li><strong>Women‚Äôs Hygiene</strong>:
<ul>
<li>Q2 loss: <strong>‚Çπ125.74 lakhs</strong> (vs.¬†profit of ‚Çπ14.85 lakhs in Q1), suggesting <strong>demand erosion or higher promotional costs</strong>.</li>
<li>Segmental profitability remains negative (H1 FY26: loss ‚Çπ110.89 lakhs).</li>
</ul></li>
<li><strong>Beverages Segment</strong>:
<ul>
<li>Significant loss in Q2: <strong>‚Çπ64.87 lakhs</strong> (vs.¬†Rs. 299.82 lakhs in Q1), but still down from ‚Çπ249.70 lakhs loss in H1 FY25.</li>
<li><strong>Revenue declined 38.3% YoY</strong> in Q2 (Rs. 428.84 lakhs vs.¬†Rs. 697.30 lakhs), raising sustainability concerns.</li>
</ul></li>
</ul>
</div>
<div id="working-capital-pressure-liquidity-drains" class="section level9">
<p class="heading">2. <strong>Working Capital Pressure &amp; Liquidity Drains</strong></p>
<ul>
<li>H1 operating cash flow dropped to <strong>‚Çπ1,090.72 crores</strong> from ‚Çπ1,622 crores (H1 FY25).</li>
<li><strong>Increase in trade receivables</strong> by ‚Çπ1,708 lakhs ‚Äî a risk for <strong>cash conversion cycle</strong>.</li>
<li><strong>Inventories increased by ‚Çπ824 crores</strong> ‚Äî could indicate <strong>slow-moving stock</strong> in underperforming segments.</li>
</ul>
</div>
<div id="adverse-tax-ruling-high-uncertainty" class="section level9">
<p class="heading">3. <strong>Adverse Tax Ruling ‚Äì High Uncertainty</strong></p>
<ul>
<li><strong>Madras High Court dismissed</strong> the Company‚Äôs writ petition on <strong>lease rent revision</strong> for temple land (retroactive from 2001), with a <strong>tax demand of ~‚Çπ1.18 crore</strong> (+ interest/penalty).</li>
<li>While legal appeal is <strong>planned</strong>, no provision was made ‚Äî posing <strong>non-operational contingent liability risk</strong>.</li>
<li>If upheld, may affect <strong>profitability and cash reserves</strong>.</li>
</ul>
<hr />
</div>
</div>
<div id="growth-prospects" class="section level6">
<h6>üìà GROWTH PROSPECTS</h6>
<div id="revival-of-otc-health-segment" class="section level9">
<p class="heading">1. <strong>Revival of OTC Health Segment</strong></p>
<ul>
<li><strong>Consistent performance improvement</strong> in OTC division suggests <strong>brand strengthening and category leadership</strong>.</li>
<li>Revenue growth and better margins indicate <strong>resilient consumer demand</strong> in the Indian pharmacy OTC space.</li>
</ul>
</div>
<div id="employee-stock-ownership-plan-esop-activity" class="section level9">
<p class="heading">2. <strong>Employee Stock Ownership Plan (ESOP) Activity</strong></p>
<ul>
<li>The <strong>ESOP Trust</strong> continues to be active.</li>
<li>Recent grants (May 2024) show <strong>commitment to employee retention and alignment of incentives</strong>, fostering long-term value creation.</li>
</ul>
</div>
<div id="lean-operating-model" class="section level9">
<p class="heading">3. <strong>Lean Operating Model</strong></p>
<ul>
<li>Controlled SG&amp;A and flat administrative expenses suggest <strong>cost discipline</strong>.</li>
<li>No subsidiaries ‚Üí <strong>reduced consolidation complexity</strong> and focused operations.</li>
</ul>
</div>
<div id="digital-remote-shareholder-engagement" class="section level9">
<p class="heading">4. <strong>Digital &amp; Remote Shareholder Engagement</strong></p>
<ul>
<li>Smooth e-AGM operation with <strong>84 shareholders attending via VC/OAVM</strong>.</li>
<li>High e-voting participation ‚Äì a <strong>proxy for digital maturity</strong> and investor accessibility.</li>
</ul>
<hr />
</div>
</div>
<div id="key-risks" class="section level6">
<h6>‚ò†Ô∏è KEY RISKS</h6>
<table>
<colgroup>
<col width="15%" />
<col width="21%" />
<col width="21%" />
<col width="42%" />
</colgroup>
<thead>
<tr class="header">
<th>Risk</th>
<th>Nature</th>
<th>Impact</th>
<th>Mitigation View</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Segment Underperformance</strong></td>
<td>Operational</td>
<td><strong>Women‚Äôs hygiene and Beverages are not profitable; may drag margins</strong></td>
<td>Needs strategic review ‚Äî divestment or turnaround plans likely.</td>
</tr>
<tr class="even">
<td><strong>Tax/Regulatory Litigation</strong></td>
<td>Legal &amp; Financial</td>
<td><strong>Potential ‚Çπ1.18 crore liability + penalties</strong> if appeal fails</td>
<td>Outcome uncertain; company is contesting ‚Äî should be monitored.</td>
</tr>
<tr class="odd">
<td><strong>Liquidity &amp; Receivables</strong></td>
<td>Financial</td>
<td><strong>High working capital investment</strong> affecting cash flow</td>
<td>Must improve collection and inventory turnover in weaker segments.</td>
</tr>
<tr class="even">
<td><strong>Input Cost Volatility</strong></td>
<td>Macro</td>
<td>Rising cost of materials (up 39% YoY in H1)</td>
<td>Needs hedging or supplier renegotiation.</td>
</tr>
<tr class="odd">
<td><strong>Brand Competition in OTC</strong></td>
<td>Market</td>
<td>Competing with Dabur, Vicco, Cipla</td>
<td>OTC growth is positive ‚Äî requires continued marketing investment.</td>
</tr>
</tbody>
</table>
<hr />
</div>
<div id="conclusion-outlook" class="section level6">
<h6>üèÅ Conclusion &amp; Outlook</h6>
<div id="bullish-signals" class="section level9">
<p class="heading">‚úÖ <strong>Bullish Signals</strong></p>
<ul>
<li>Strong, growing OTC business</li>
<li>High shareholder confidence</li>
<li>Healthy cash reserves &amp; low leverage</li>
<li>Consistent dividends</li>
<li>Transparent governance</li>
</ul>
</div>
<div id="cautions" class="section level9">
<p class="heading">‚õî <strong>Cautions</strong></p>
<ul>
<li>Loss-making segments</li>
<li>Adverse tax order (appeal underway)</li>
<li>Working capital inefficiencies</li>
</ul>
</div>
<div id="overall-rating-neutrally-positive-cautious-optimism" class="section level9">
<p class="heading">üîÆ <strong>Overall Rating: Neutrally Positive (Cautious Optimism)</strong></p>
<p>Amrutanjan Health Care is <strong>navigating a transition phase</strong> ‚Äî capitalizing on core OTC strength while managing underperforming segments and regulatory overhangs. The company‚Äôs <strong>financial health, governance, and dividend policy</strong> make it attractive for income investors. However, <strong>sustainability of non-OTC businesses</strong> and <strong>resolution of legal issues</strong> will be <strong>key monitoring points</strong>.</p>
<hr />
</div>
<div id="recommendations" class="section level9">
<p class="heading">üìå Recommendations:</p>
<ol style="list-style-type: decimal">
<li><strong>Monitor Q3 FY26 performance</strong>, especially <strong>Women‚Äôs Hygiene and Beverages</strong>, for turnaround signs.</li>
<li><strong>Track progress on GST/Lease appeal</strong> ‚Äî potential write-down in future quarters.</li>
<li><strong>Assess inventory and receivables trend</strong> ‚Äî signs of improvement would support cash flow recovery.</li>
<li>Consider investment for <strong>dividend yield</strong> + <strong>OTC revival play</strong>, but with <strong>limit exposure due to segmental imbalances</strong>.</li>
</ol>
<blockquote>
<p><strong>Final Summary</strong>: Amrutanjan is a <strong>well-governed, stable dividend payer</strong> with a <strong>reviving flagship OTC segment</strong>, but faces challenges from <strong>loss-making business units and a pending legal overhang</strong>. Proceed with <strong>cautious optimism</strong>.</p>
</blockquote>
<hr />
<p><em>Note: All figures are in INR lakhs; financial data based on Ind AS compliant statements. Market risk not factored beyond published filings.</em></p>
</div>
</div>
</div>
</div>

&nbsp;
&nbsp;
<hr />
<p style="text-align: center;">Copyright &copy; 2023 SAS Data Analytics Pvt. Ltd. All rights reserved.</p>
<p style="text-align: center;"><a href="https://github.com/stockviz/reports/issues">&#x1F41E;</a></p>



</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
